Close Menu
  • Home
  • Markets
    • Earnings
  • Banks
    • Crypto
    • Investing
  • Business
    • Retail
  • industry
    • Finance
    • Energy
    • Real Estate
  • Politics
  • Editorials
Facebook X (Twitter) Instagram
Facebook LinkedIn
Financial Market News
Subscribe Now
  • Home
  • Markets
    • Earnings
  • Banks
    • Crypto
    • Investing
  • Business
    • Retail
  • industry
    • Finance
    • Energy
    • Real Estate
  • Politics
  • Editorials
Financial Market News
You are at:Home»Posts Tagged "Novo Nordisk A/S" (Page 2)

Restaurants add protein, fiber for weight loss drug users

By FinMar NewsMarch 23, 2026

A mini burger, mini fries and mini beer, Clinton Hall’s “Teeny Weeny Mini Meal”, is pictured next to a regular-sized combo on Dec. 8, 2025 in…

FDA approves high dose version of Novo Nordisk’s obesity drug Wegovy

By FinMar NewsMarch 19, 2026

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, Feb. 4, 2026.Tom Little | ReutersThe Food and…

Jim Cramer’s update on our AI stocks and the rest of the portfolio

By FinMar NewsMarch 2, 2026

On Friday, the CNBC Investing Club held its February Monthly Meeting, where Jim Cramer and Director of Portfolio Analysis ran through each stock in the portfolio.…

Novo Nordisk to slash Wegovy, Ozempic U.S. list prices by up to 50%

By FinMar NewsFebruary 24, 2026

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, Feb. 4, 2026.Tom Little | ReutersNovo Nordisk on…

CEO says it will get worse before it gets better

By FinMar NewsFebruary 9, 2026

Just as Novo Nordisk showed signs of a recovery, another cold shower hit investors as the drugmaker surprise pre-released its 2026 forecast late Tuesday, sending shares…

Novo Nordisk sues Hims & Hers over compounded obesity drugs

By FinMar NewsFebruary 9, 2026

Novo Nordisk on Monday said it is suing online telehealth provider Hims & Hers for mass marketing cheaper, unapproved copies of the drugmaker’s new Wegovy obesity…

This pharma stock just got whacked — there’s still a major catalyst ahead

By FinMar NewsJanuary 18, 2026

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading…

Anthropic’s Amodei siblings may hold the key to generative AI

By FinMar NewsJanuary 10, 2026

SAN FRANCISCO — Daniela Amodei has an energy that’s hard to place — warm, unhurried, immediately present. She swept into a sunlit room on the ground…

Wall Street deals 2025 under Trump: Tariffs, uncertainty slow M&A

By FinMar NewsDecember 19, 2025

The Wall Street Bull statue covered in snow on Nov. 15, 2018.Erik Mcgregor | Lightrocket | Getty ImagesWall Street expected U.S. mergers and acquisitions to roar…

Eli Lilly obesity pill maintains weight loss after Wegovy, Zepbound 

By FinMar NewsDecember 18, 2025

The Eli Lilly & Co. logo at the company’s Digital Health Innovation Hub facility in Singapore, on Thursday, Nov. 14, 2024.Ore Huiying | Bloomberg | Getty…

Previous 1 2 3 4 … 7 Next
Energy News

Trump’s energy deals are about to face a wave of investigations by

Democrats Seize Congress, Statehouses in Referendum on the Economy

What a Democratic sweep means for stocks

Climate science helps support nuclear sector

Banks News

RBI proposes ₹100 crore limit on bank loans for agri infrastructure |

Zacks Industry Outlook Highlights ICICI, Canadian Imperial Bank and KB

Bank Of Industry, IFC Sign US$50 Million Loan As Part Of Up To Us$100

DPM Dar Reviews Measures To Strengthen Banking Channels, Support Industry

Real Estate News

San Francisco’s shuttered downtown mall could be torn down under new

DEMIRE delivers Q3 2026 results in line with expectations and confirms

Pinsent Masons guides Penta Real Estate on Staycity Group joint venture

Massachusetts REALTORS Charitable Foundation Awards $27,000 in Grants to 18

© 2026 finmar.news

Type above and press Enter to search. Press Esc to cancel.

Social Media Auto Publish Powered By : XYZScripts.com